Results 1 to 10 of about 15,148 (241)

Optimization of a Loop-Mediated Isothermal Amplification Assay as a Point-of-Care Tool for the Detection of Wuchereria bancrofti in Human Blood in Tana River Delta, Kenya [PDF]

Journal of Parasitology Research, 2021
Introduction. Accurate detection of filarial parasites in humans and vectors is essential for the implementation and evaluation of Global and National Programs to eliminate lymphatic filariasis.
Kinyatta Nancy, Wambua Lillian, Mutahi Wilkinson, Mugasa Claire, Kamau Luna, Wachira Dorcas, Githae Rosemary, Lusweti Japheth, Ichugu Christine, Waigi Emily, Kagai Jim   +10 more
doaj   +5 more sources

Single-Dose Triple-Drug Therapy for Wuchereria bancrofti - 5-Year Follow-up. [PDF]

N Engl J Med, 2020
Single-dose therapy for Wuchereria bancrofti Five years after treatment with a single dose of ivermectin plus diethylcarbamazine plus albendazole for bancroftian filariasis as part of a clinical tr...
King CL, Weil GJ, Kazura JW.
europepmc   +4 more sources

Biodiversity of mosquitoes and Mansonia uniformis as a potential vector of Wuchereria bancrofti in Hulu Sungai Utara District, South Kalimantan, Indonesia. [PDF]

Vet World, 2020
Background and Aim: Lymphatic filariasis, also known as elephantiasis, still remains a problem in Indonesia. The primary causative species of this disease are the filarial worms Wuchereria bancrofti and Brugia spp.
Ridha MR, Rahayu N, Hairani B, Perwitasari D, Kusumaningtyas H.   +4 more
europepmc   +4 more sources

Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals. [PDF]

Pathogens, 2023
Approximately 51 million individuals suffer from lymphatic filariasis (LF) caused mainly by the filarial worm Wuchereria bancrofti. Mass drug administration (MDA) programs led to a significant reduction in the number of infected individuals, but the ...
Tamadaho RSE, Osei-Mensah J, Arndts K, Debrah LB, Debrah AY, Layland LE, Hoerauf A, Pfarr K, Ritter M.   +8 more
europepmc   +2 more sources

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections. [PDF]

PLoS Negl Trop Dis, 2022
Background Lymphatic filariasis (LF) is a neglected tropical disease caused by the filarial nematodes Wuchereria bancrofti, Brugia malayi and Brugia timori.
Greene SE, Fischer K, Choi YJ, Curtis KC, Budge PJ, Mitreva M, King CL, Fischer PU, Weil GJ.   +8 more
europepmc   +2 more sources

Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania. [PDF]

PLoS One, 2022
Background Lymphatic filariasis (LF) affects more than 120 million people globally. In Tanzania, nearly six million people are estimated to live with clinical manifestations of the disease.
Lupenza ET, Gasarasi DB, Minzi OM.
europepmc   +2 more sources

COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection. [PDF]

PLoS Negl Trop Dis, 2020
With the evolution of the Coronavirus Disease 2019 (COVID-19) pandemic, the number of patients brought to medical attention has increased. This has led to the unmasking of many coexisting occult infections and comorbidities such as tuberculosis, dengue ...
Mohamed MFH, Mohamed SF, Yousaf Z, Kohla S, Howady F, Imam Y.   +5 more
europepmc   +2 more sources

Evaluation of Actin-1 Expression in Wild Caught Wuchereria bancrofti-Infected Mosquito Vectors. [PDF]

J Pathog, 2020
Background Wuchereria bancrofti is the major cause of lymphatic filariasis transmitted by mosquito vectors. In the vector-parasite interaction and among other proteins, actin-1 has been implicated for successful transmission of the pathogen in laboratory-
Entonu ME, Muhammad A, Ndams IS.
europepmc   +2 more sources

Identification and prioritisation of potential vaccine candidates using subtractive proteomics and designing of a multi-epitope vaccine against Wuchereria bancrofti. [PDF]

Sci Rep
This study employed subtractive proteomics and immunoinformatics to analyze the Wuchereria bancrofti proteome and identify potential therapeutic targets, with a focus on designing a vaccine against the parasite species.
Aarthy M, Pandiyan GN, Paramasivan R, Kumar A, Gupta B.   +4 more
europepmc   +2 more sources

Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa. [PDF]

PLoS One, 2020
Background Lymphatic filariasis (LF) is widely endemic in Côte d’Ivoire, and elimination as public health problem (EPHP) is based on annual mass drug administration (MDA) using ivermectin and albendazole.
Yokoly FN, Zahouli JBZ, Méite A, Opoku M, Kouassi BL, de Souza DK, Bockarie M, Koudou BG.   +7 more
europepmc   +2 more sources